Too Much Weight Loss With Retatrutide? Transgender Doc Sued; Ice Age Growth Disorder

(MedPage Today) — Some participants in a weight-loss trial of retatrutide, an investigational triple-hormone receptor agonist, dropped out because they thought they were losing too much weight. (New York Times)
Meanwhile, UBT251, another investigational…